Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey J Winham

Showing results (131-140 of 207) with videos related to

Pageof 21
Sort By:
Breast Cancer Research and Treatment|May 3, 2022
Serum hormone levels and normal breast histology among premenopausal womenMark E Sherman, Thomas de Bel, Michael G Heckman, et al.
The International Journal of Neuropsychopharmacology|October 30, 2012
Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional statesVictor M Karpyak, Stacey J Winham, Ulrich W Preuss, et al.
Breast Cancer Research and Treatment|August 12, 2017
NanoString-based breast cancer risk prediction for women with sclerosing adenosisStacey J Winham, Christine Mehner, Ethan P Heinzen, et al.
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous CarcinomaChen Wang, Matthew S Block, Julie M Cunningham, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
Journal of Affective Disorders|May 11, 2022
Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studiesManuel Gardea-Resendez, Stacey J Winham, Francisco Romo-Nava, et al.
Breast Cancer Research : BCR|July 12, 2022
Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligenceJoshua Ogony, Thomas de Bel, Derek C Radisky, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Pageof 21

Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|May 3, 2022
Serum hormone levels and normal breast histology among premenopausal womenMark E Sherman, Thomas de Bel, Michael G Heckman, et al.
The International Journal of Neuropsychopharmacology|October 30, 2012
Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional statesVictor M Karpyak, Stacey J Winham, Ulrich W Preuss, et al.
Breast Cancer Research and Treatment|August 12, 2017
NanoString-based breast cancer risk prediction for women with sclerosing adenosisStacey J Winham, Christine Mehner, Ethan P Heinzen, et al.
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous CarcinomaChen Wang, Matthew S Block, Julie M Cunningham, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
Journal of Affective Disorders|May 11, 2022
Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studiesManuel Gardea-Resendez, Stacey J Winham, Francisco Romo-Nava, et al.
Breast Cancer Research : BCR|July 12, 2022
Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligenceJoshua Ogony, Thomas de Bel, Derek C Radisky, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Pageof 21